Saptak Chem seeks shareholder approval for Ayush Tated as managing director

scanx
Reviewed by
Naman SScanX News Team
Key Highlights

Saptak Chem and Business Limited holds its 47th AGM on August 28, 2026, to appoint Ayush Vinod Kumar Tated as Managing Director with a ₹15,000 monthly salary under Schedule V and regularize two independent directors. This governance update follows a capital reduction and aims to stabilize operations amid business revival efforts.

powered bylight_fuzz_icon
47132076

*this image is generated using AI for illustrative purposes only.

Saptak Chem and Business Limited has scheduled its 47th Annual General Meeting (AGM) for August 28, 2026, to secure shareholder consent for appointing Ayush Vinod Kumar Tated as Managing Director and regularizing the roles of two independent directors. The meeting, conducted via Video Conferencing, addresses critical governance structures following a significant capital reduction approved by the National Company Law Tribunal (NCLT) Ahmedabad in June 2025. Shareholders will vote on resolutions that solidify leadership amid the company’s business revival efforts, which include a recent ₹5 crore purchase order secured for FY27.

The Board of Directors convened the meeting pursuant to Section 101 of the Companies Act, 2013, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. P.H. Shah & Co., Chartered Accountants, served as statutory auditors for FY26, issuing an unmodified audit report. Mrs. Rupal Patel, a Practicing Company Secretary, was appointed as the Scrutinizer for the e-voting process. The agenda includes ordinary business such as adopting audited financial statements for FY26 and special resolutions regarding director appointments.

Key Resolutions and Director Appointments

The primary focus is formalizing leadership roles. Ayush Vinod Kumar Tated, currently serving as Executive Director since January 09, 2026, is proposed for appointment as Managing Director for a five-year term ending January 08, 2031. His monthly remuneration is set at ₹15,000, subject to Schedule V of the Companies Act, 2013, due to inadequate profits. Additionally, shareholders will vote to regularize Jubin Premji Gada and Rinku Saini as Non-Executive Independent Directors for five-year terms commencing August 28, 2026.

Resolution Item Description Type Key Details
Item 1 Adoption of Audited Financial Statements Ordinary FY26 ended March 31, 2026
Item 2 Re-appointment of Ayush Tated as Executive Director Ordinary Retires by rotation
Item 3 Regularization of Ayush Tated as Executive Director Special Effective from Jan 09, 2026
Item 4 Appointment of Ayush Tated as Managing Director Special Term: Jan 09, 2026 – Jan 08, 2031
Item 5 Appointment of Jubin Gada as Independent Director Special Term: Aug 28, 2026 – Aug 27, 2031
Item 6 Appointment of Rinku Saini as Independent Director Special Term: Aug 28, 2026 – Aug 27, 2031

Voting Process and Timeline

Remote e-voting will be open from August 25, 2026, at 09:00 a.m. to August 27, 2026, at 05:00 p.m., via the NSDL e-voting system. The record date for determining voting entitlements is August 21, 2026. Members holding shares in demat or physical form can cast votes electronically; proxy appointments are not permitted for this VC-held meeting. The Register of Members and Share Transfer Books will remain closed from August 22, 2026, to August 28, 2026.

What the Numbers Show

The appointment of a Managing Director with a fixed salary under Schedule V highlights the company’s continued focus on cost containment rather than profit-linked incentives. With Q1FY26 revenue at zero and losses narrowing primarily through expense reduction, the leadership transition aims to stabilize operations. The addition of two independent directors strengthens corporate governance, aligning with regulatory requirements while the company navigates its revival phase following capital reduction approvals from NCLT Ahmedabad in June 2025.

How will the appointment of a Managing Director under Schedule V remuneration impact Saptak Chem's ability to attract and retain top-tier executive talent during its revival phase?

What specific operational strategies is the new leadership team implementing to convert the recent ₹5 crore purchase order into sustainable revenue growth for FY27?

Given the history of capital reduction and NCLT involvement, what are the remaining regulatory or financial hurdles Saptak Chem must clear to fully normalize its market standing?

like19
dislike